Inspire Medical Systems
INSPInspire Medical Systems is a medical technology company that develops and commercializes minimally invasive neurostimulation solutions for patients with obstructive sleep apnea (OSA).
Earnings
Next report
Nov 2, 2026 (Today)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
Inspire Medical Systems is a medical technology company that develops and commercializes minimally invasive neurostimulation solutions for patients with obstructive sleep apnea (OSA). Its proprietary technology provides a closed-loop system that monitors breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway, serving as a primary alternative for patients who cannot tolerate Continuous Positive Airway Pressure (CPAP) therapy.
The company is a first-mover in the hypoglossal nerve stimulation market with the first FDA-approved closed-loop neurostimulation technology for OSA.
FAQ
- What is Inspire Medical Systems's market cap?
- Inspire Medical Systems (INSP) has a market capitalization of $2.1B and trades on NYSE.
- What is Inspire Medical Systems's revenue and profitability?
- Inspire Medical Systems generated $898.7M in trailing twelve-month revenue with net income of $135.0M, representing a net margin of 15.0%. Gross margin stands at 86.1%, with free cash flow of $117.1M. The latest reported period is Q2 2026.
- Who are Inspire Medical Systems's competitors?
- Inspire Medical Systems's key competitors include LivaNova, ResMed, Philips, and others. These companies compete in similar markets and product categories.
- Where is Inspire Medical Systems headquartered?
- Inspire Medical Systems is headquartered in United States of America and employs approximately 1,011 people. It has been publicly traded since 2018.
